PVLA
PVLA
US6979471090
Palvella Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2B EUR
2.2B EUR
1.78B EUR
1.3B EUR
Enterprise Value
1.66B EUR
2.01B EUR
1.58B EUR
1.24B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-18.51x
--
--
--
Price to Sales
--
--
--
--
Price to Book
9.21x
10.14x
7.68x
46.31x
EV/Revenue
--
--
--
--
EV/EBITDA
--
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1.27%
-1.66%
-1.63%
-1.41%
ende